Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Enforcement-nir
Subscribe today for access to
Articles and Reports
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Theranos Settles with CMS and Arizona Attorney General
From - National Intelligence Report
After facing federal and state government scrutiny for more than a year, Theranos has reached agreements with the Centers for Medicare & Medicaid Services (CMS) and the Arizona Attorney General to…
CMS, OIG Reps Address PAMA, Fraud Enforcement at ACLA Annual Meeting
...
Already a member? Log in here
OIG and DOJ Provide Tips for Determining Effectiveness of Compliance Programs
...
Already a member? Log in here
Health Care Fraud and Abuse Program Faces Declining ROI
From - National Intelligence Report
The federal government's return on investment (ROI) in the fight against health care fraud continues a steady decline according to the latest numbers reported for the Health Care Fraud and…
Breach Notification Violation Ends in $475,000 Settlement
...
Already a member? Log in here
DOJ Surveys False Claims Victories for 2016
From - National Intelligence Report
As we closed out the calendar year, the U.S. Department of Justice (DOJ) reflected on its successes for the fiscal year 2016 (FY 2016) which ended…
Labs Beware: New Rules Impose Harsher Civil Monetary Penalties
...
Already a member? Log in here
Semiannual OIG Report to Congress Outlines Challenges as Well as Successes
...
Already a member? Log in here